FDA removing REMS from several CAR-T cell therapies positive for these 3 stocks - William Blair Jun 27, 2025 11:31AM
Autolus Therapeutics to Participate in Upcoming Investor Conferences May 29, 2025 04:05PM
Autolus Announces Partial Exercise of Underwriters' Option to Purchase Additional ADSs Dec 21, 2022 04:01PM
Autolus Announces Partial Exercise of Underwriters' Option to Purchase Additional ADSs Dec 21, 2022 04:01PM
Autolus Therapeutics (AUTL) Prices 75M Share Offering at $2 Dec 9, 2022 06:36AM


Dec 8, 2022 09:11PM Autolus Announces Pricing of Public Offering
Dec 8, 2022 09:11PM Autolus Announces Pricing of Public Offering
Dec 8, 2022 04:04PM Autolus Therapeutics (AUTL) Announces Proposed Public Offering in the United States
Dec 8, 2022 04:03PM Autolus Announces Proposed Public Offering in the United States
Dec 8, 2022 04:03PM Autolus Announces Proposed Public Offering in the United States
Jul 6, 2022 07:00AM Autolus Therapeutics to Participate in William Blair’s Biotech Focus Conference 2022, New York, July 12 – 13, 2022
Jul 6, 2022 07:00AM Autolus Therapeutics to Participate in William Blair’s Biotech Focus Conference 2022, New York, July 12 – 13, 2022
Mar 16, 2022 09:30AM Reaction Biology Announces Closing of Growth Investment from Cobepa and Chief Executive Officer Transition
Jul 8, 2021 07:00AM Autolus Therapeutics to Report Second Quarter 2021 Financial Results on August 5, 2021, and will Participate in the William Blair Biotech Focus Conference 2021 on July 14, 2021
Jul 8, 2021 07:00AM Autolus Therapeutics to Report Second Quarter 2021 Financial Results on August 5, 2021, and will Participate in the William Blair Biotech Focus Conference 2021 on July 14, 2021
Jan 27, 2020 04:00PM Autolus Announces Closing of Public Offering
Jan 27, 2020 04:00PM Autolus Announces Closing of Public Offering
Jan 23, 2020 05:51AM Autolus Therapeutics (AUTL) Prices 7.25M ADS Offering at $11/ADS
Jan 22, 2020 09:41PM Autolus Announces Pricing of Public Offering
Jan 22, 2020 09:41PM Autolus Announces Pricing of Public Offering
Jan 22, 2020 04:42PM Autolus Therapeutics (AUTL) Announces 7.25M Proposed Public Offering of ADSs
Jan 22, 2020 04:41PM Autolus Announces Proposed Public Offering in the United States
Jan 22, 2020 04:41PM Autolus Announces Proposed Public Offering in the United States
Apr 15, 2019 04:02PM Autolus Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares
Apr 15, 2019 04:02PM Autolus Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares
Apr 11, 2019 05:49AM Autolus Therapeutics (AUTL) Prices 4.2M ADS Offering at $24/ADS
Apr 10, 2019 09:19PM Autolus Announces Pricing of Public Offering
Apr 10, 2019 09:19PM Autolus Announces Pricing of Public Offering
Apr 8, 2019 04:40PM Autolus Therapeutics (AUTL) Plans Offering of 4M ADSs
Apr 8, 2019 04:40PM Autolus Announces Proposed Public Offering in the United States
Apr 8, 2019 04:40PM Autolus Announces Proposed Public Offering in the United States
Jul 17, 2018 06:08AM William Blair Starts AUTL (AUTL) at Outperform
Jun 26, 2018 09:15AM Autolus Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares
Jun 26, 2018 05:15AM Autolus Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares
Jun 22, 2018 11:48AM Autolus Therapeutics (AUTL) IPO Opens 65% Higher